\-\ Texto\\:\\ \ \(0\)\
\-\ none\\ available\ \(6\)\
\-\ fluroscopic\\ ercp\\ images\\ after\\ contrast\\ infusion\\ into\\ the\\ common\\ bile\\ duct\\ demonstrate\\ multifocal\\ areas\\ of\\ stricture\\ and\\ dilatation\\ in\\ the\\ intrahepatic\\ and\\ extrahepatic\\ ducts\\.\ \(0\)\
\-\ primary\\ sclerosing\\ cholangitis\ \(2\)\
\-\ primary\\ sclerosing\\ cholangitis\ \(2\)\
\-\ secondary\\ sclerosing\\ cholangitis\\ due\\ to\\ \ \(0\)\
\-\ \\ \\-\\ inflammatory\\ bowel\\ disease\\ \ \(0\)\
\-\ \\ \\-\\ bacterial\\/aids\\ cholangitis\ \(0\)\
\-\ \\ \\-\\ chronic\\ obstruction\\ from\\ stones\\ \ \(0\)\
\-\ \\ \\-\\ chemotherapy\\ related\ \(0\)\
\-\ \\ \\-\\ ischemia\ \(0\)\
\-\ diffuse\\ cholangiocarcinoma\ \(0\)\
\-\ with\\ pain\\,\\ jaundice\\,\\ pruritus\\ and\\ elevated\\ liver\\ function\\ tests\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cholangitis\\:\\ 0\\.5808237865140591\ \(0\)\
\-\ sclerosing\\:\\ 0\\.39680345918511567\ \(0\)\
\-\ fluroscopic\\:\\ 0\\.17028672207060364\ \(0\)\
\-\ pruritus\\:\\ 0\\.17028672207060364\ \(0\)\
\-\ primary\\:\\ 0\\.15441440769463513\ \(0\)\
\-\ ercp\\:\\ 0\\.14704130952803066\ \(0\)\
\-\ infusion\\:\\ 0\\.14434263584895538\ \(0\)\
\-\ extrahepatic\\:\\ 0\\.14434263584895538\ \(0\)\
\-\ cholangiocarcinoma\\:\\ 0\\.13977216051941835\ \(0\)\
\-\ jaundice\\:\\ 0\\.1337864634469259\ \(0\)\
\-\ intrahepatic\\:\\ 0\\.131784028752438\ \(0\)\
\-\ ducts\\:\\ 0\\.12951277827633534\ \(0\)\
\-\ bile\\:\\ 0\\.12192228628602736\ \(0\)\
\-\ multifocal\\:\\ 0\\.12192228628602736\ \(0\)\
\-\ stricture\\:\\ 0\\.12161867315089026\ \(0\)\
\-\ tests\\:\\ 0\\.12016041795666725\ \(0\)\
\-\ stones\\:\\ 0\\.11852918267133326\ \(0\)\
\-\ ischemia\\:\\ 0\\.10874765484941311\ \(0\)\
\-\ duct\\:\\ 0\\.10808560183608375\ \(0\)\
\-\ dilatation\\:\\ 0\\.10249948568434644\ \(0\)\
\-\ function\\:\\ 0\\.10163130992447941\ \(0\)\
\-\ related\\:\\ 0\\.09542091451828945\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.08915746482271507\ \(0\)\
\-\ obstruction\\:\\ 0\\.08794920768920632\ \(0\)\
\-\ liver\\:\\ 0\\.08661860503525806\ \(0\)\
\-\ elevated\\:\\ 0\\.08559741985179321\ \(0\)\
\-\ areas\\:\\ 0\\.08524802198692576\ \(0\)\
\-\ available\\:\\ 0\\.08519032443537759\ \(0\)\
\-\ inflammatory\\:\\ 0\\.08490408368761303\ \(0\)\
\-\ bowel\\:\\ 0\\.08058026958778998\ \(0\)\
\-\ diffuse\\:\\ 0\\.07874303741704776\ \(0\)\
\-\ and\\:\\ 0\\.07783767058648959\ \(0\)\
\-\ chronic\\:\\ 0\\.07453012983678518\ \(0\)\
\-\ secondary\\:\\ 0\\.07442387893066048\ \(0\)\
\-\ due\\:\\ 0\\.07217550197571646\ \(0\)\
\-\ common\\:\\ 0\\.07120814616542409\ \(0\)\
\-\ none\\:\\ 0\\.06861894511008487\ \(0\)\
\-\ into\\:\\ 0\\.06674670094269444\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06527630458830887\ \(0\)\
\-\ contrast\\:\\ 0\\.06100810654308945\ \(0\)\
\-\ after\\:\\ 0\\.060912278776097756\ \(0\)\
\-\ images\\:\\ 0\\.05808087435653642\ \(0\)\
\-\ disease\\:\\ 0\\.0527065485270574\ \(0\)\
\-\ the\\:\\ 0\\.05010841492658826\ \(0\)\
\-\ from\\:\\ 0\\.04986798028360985\ \(0\)\
\-\ pain\\:\\ 0\\.04493077396677214\ \(0\)\
\-\ to\\:\\ 0\\.03139030192791091\ \(0\)\
\-\ in\\:\\ 0\\.03123579892683328\ \(0\)\
\-\ with\\:\\ 0\\.024586647399349494\ \(0\)\
\-\ of\\:\\ 0\\.024571965655725374\ \(0\)\
